4.8 Article

Mutations and variants of ONECUT1 in diabetes

Journal

NATURE MEDICINE
Volume 27, Issue 11, Pages 1928-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41591-021-01502-7

Keywords

-

Funding

  1. Boehringer Ingelheim Ulm University BioCenter (BIU)
  2. ANR-DFG collaborative research project [ANR-18-CE92-0031, DFG KL 2544/5-1]
  3. Deutsche Forschungsgemeinschaft (DFG) grant [KL 2544/6-1, KL 2544/7-1, KL 2544/8-1, KL 2544/1-2, GE 2811/3-1, SFB1074/A3, OS287/4-1]
  4. Agence Nationale pour la Recherche [ANR-09-GENO-021]
  5. European Foundation for the Study of Diabetes/JDRF/Novo Nordisk
  6. Assistance Publique-Hopitaux de Paris Programme Hospitalier de Recherche Clinique (project DIAGENE)
  7. France Genomique (project DIAPED)
  8. E: MED Consortia Fibromap - German Ministry of Education and Science (BMBF)
  9. NIH [DK068471, DK105541, GM008666, DK105831]
  10. Centre of Excellence Metabolic Disorders Baden-Wuerttemberg, Germany [DFG-GrK1041]
  11. Ministry of Education, Singapore [MOE2018-T2-1-085]
  12. France Genomique National infrastructure, Investissements d'Avenir program [ANR-10-INBS-09]

Ask authors/readers for more resources

This study demonstrates that mutations in ONECUT1 can cause monogenic recessive syndromic diabetes and define a subgroup of patients with early-onset diabetes who respond well to treatment. Additionally, variations in ONECUT1 are associated with multifactorial type 2 diabetes. The loss of ONECUT1 impairs pancreatic progenitor formation and endocrine program, highlighting its broad contribution to diabetes pathogenesis.
Genes involved in distinct diabetes types suggest shared disease mechanisms. Here we show that One Cut Homeobox 1 (ONECUT1) mutations cause monogenic recessive syndromic diabetes in two unrelated patients, characterized by intrauterine growth retardation, pancreas hypoplasia and gallbladder agenesis/hypoplasia, and early-onset diabetes in heterozygous relatives. Heterozygous carriers of rare coding variants of ONECUT1 define a distinctive subgroup of diabetic patients with early-onset, nonautoimmune diabetes, who respond well to diabetes treatment. In addition, common regulatory ONECUT1 variants are associated with multifactorial type 2 diabetes. Directed differentiation of human pluripotent stem cells revealed that loss of ONECUT1 impairs pancreatic progenitor formation and a subsequent endocrine program. Loss of ONECUT1 altered transcription factor binding and enhancer activity and NKX2.2/NKX6.1 expression in pancreatic progenitor cells. Collectively, we demonstrate that ONECUT1 controls a transcriptional and epigenetic machinery regulating endocrine development, involved in a spectrum of diabetes, encompassing monogenic (recessive and dominant) as well as multifactorial inheritance. Our findings highlight the broad contribution of ONECUT1 in diabetes pathogenesis, marking an important step toward precision diabetes medicine. Clinical and genetic phenotyping of consanguineous family cases of neonatal syndromic diabetes and type 2 diabetes, combined with in-depth functional studies in pluripotent stem cells, reveals a role for genetic variants of ONECUT1 in monogenic and multifactorial diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available